−64.3
Spero Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−7.73
FY23:
−33.0
FY24:
−23.4
FY25:
−12.6
Change from FY21 to FY23
millions USD
FY21:
7.67
FY22:
33.8
FY23:
0
FY24:
–
FY25:
–
Change from FY21 to FY24
millions USD
FY21:
84.1
FY22:
−29.6
FY23:
0.22
FY24:
0
FY25:
–
millions USD
FY21:
27.4
FY22:
−3.48
FY23:
−32.8
FY24:
−23.4
FY25:
−12.6
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
−12.6
All amounts in millions USD